Filed before 2025Filed 12 July 2019
Esperance Pharmaceuticals, Inc raised $1M
Esperance Pharmaceuticals, Inc, a biotech company based in Houston, TX, raised $1M in a new debt round, according to a filing dated 12 July 2019.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 12 July 2019
- Round
- Debt round
- Amount sold
- $1M
- Offering size
- $1M
- Investors so far
- 1
- Based in
- Houston, TX
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 9% of the 1,781 tracked raises with an amount filed in 2019, and than 8% of the 146 in biotech.
Esperance Pharmaceuticals, Inc in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 12 Jul 2019 | New filing | $1M | This raise |
More with Cancer Focus on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.